Recently, not only has MFG-E8 expression emerged as a molecular hallmark of adverse cardiovascular remodeling with age41–44, but MFG-E8 signaling has also been found to mediate the vascular outcomes of cellular and matrix responses to the hostile stresses associated with hypertension, diabetes, and atherosclerosis45–49. Here, MFGE8 is linked to diabetes mellitus.